Pharmaneek
Install Pharmaneek
Quick access · Full screen · Faster

Add to Desktop

Use Chrome or Edge for the best install experience.

Returning-patient pricing, exclusive savings on your refills.

Pharmaneek Health Intelligence

Drug Safety & Health Insights

Stay informed with the latest FDA drug recalls, safety alerts, and expert pharmacy insights , curated by our clinical team.

FDA Data

Recent Drug Recalls

Recent drug recall information sourced from the FDA's enforcement database.

Source: openFDA. Data retrieved . Report dates appear on each entry; FDA reports may change.

Not Yet Classified , MinorSep 3, 2026

OurPharma LLC

fentaNYL Citrate, 1,000 mcg/100 mL (10mcg/mL) Injection solution in 100 mL, 0.9% NaCl Bag, OurPharma LLC, 2512 S. City L

Reason: Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026).

Class III , MinorAug 31, 2026

Supernus Pharmaceuticals, Inc.

Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solut

Reason: Failed dissolution specifications.

Class II , ModerateAug 26, 2026

Mylan Pharmaceuticals Inc

Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only, Manufactured

Reason: Failed Dissolution Specifications

Class III , MinorAug 25, 2026

Ajanta Pharma USA Inc

Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewa

Reason: Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.

Class II , ModerateAug 24, 2026

Hikma Pharmaceuticals USA INC.

Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bott

Reason: Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).

Class II , ModerateAug 24, 2026

Teva Pharmaceuticals USA, Inc

traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zag

Reason: Presence of Foreign Tablets/Capsules

From Our Clinical Team

Pharmacy Insights & Health Tips

Expert advice and health information curated by our licensed pharmacists.

💊
Patient Education

Medication Adherence Matters

Studies show that nearly 50% of patients don't take medications as prescribed. Our UneekDose packaging system helps you stay on track by sorting your meds by date and time.

🛡️
Cost Savings

Generic vs. Brand Name

The FDA requires generics to have the same active ingredient, strength, and dosage form. Choosing generics can save you up to 85% , and we always check for the most affordable option.

🌡️
Seasonal Health

Seasonal Health: Flu Prevention

Getting vaccinated is your best defense against influenza. Ask your pharmacist about flu shots, and remember , hand washing and staying home when sick help protect your community.

⚠️
Safety

Drug Interaction Awareness

More than 70% of Americans take at least one prescription drug. Always inform your pharmacist about all medications you take, including over-the-counter drugs and supplements.

📦
Best Practices

Proper Medication Storage

Heat, moisture, and light can damage medications. Store most meds in a cool, dry place away from bathrooms. Our delivery packaging is designed to maintain medication integrity.

💡
Patient Education

Understanding Your Prescription

Always read the patient information leaflet that comes with your prescription. If anything is unclear about dosage, timing, or side effects, our pharmacists are available 24/7.

Recent Adverse Event Reports

The latest reported drug adverse events submitted to the FDA's safety monitoring system.

Source: openFDA. Data retrieved . Report dates appear on each entry; FDA reports may change.

TREMFYA

Incorrect dose administered

Jun 30, 2026US
SKYCLARYSSerious

Brain natriuretic peptide increased, Cardiac failure

Jun 30, 2026EU
RAVULIZUMABSerious

Blood potassium increased, Glaucoma, Blood creatinine abnormal, Glomerular filtration rate increased

Jun 30, 2026US
PITAVASTATINSerious

Movement disorder, Myopathy, Myalgia

Jun 30, 2026
TACROLIMUSSerious

Warm autoimmune haemolytic anaemia

Jun 30, 2026US
FINTEPLASerious

Pulmonary valve incompetence

Jun 30, 2026US

Important Disclaimer

The drug recall and adverse event data displayed on this page is sourced directly from the U.S. Food and Drug Administration (FDA) openFDA public API. This information is provided for educational and awareness purposes only. It does not constitute medical advice. Always consult your physician or pharmacist before making any changes to your medication regimen.